U.S. Pharmaceuticals & Biotech Healthy potentially undervalued

Amphastar Pharmaceuticals

Market Cap: US$1.2b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

CorMedix

Market Cap: US$872.0m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Catalyst Pharmaceuticals

Market Cap: US$2.6b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Jazz Pharmaceuticals

Market Cap: US$8.3b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Prestige Consumer Healthcare

Market Cap: US$3.0b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

BeOne Medicines

Market Cap: US$34.2b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Teva Pharmaceutical Industries

Market Cap: US$23.5b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Journey Medical

Market Cap: US$213.6m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

ICON

Market Cap: US$13.1b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Royalty Pharma

Market Cap: US$21.9b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Viatris

Market Cap: US$12.1b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Pacira BioSciences

Market Cap: US$960.7m

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Exelixis

Market Cap: US$10.4b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Halozyme Therapeutics

Market Cap: US$7.6b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

ACADIA Pharmaceuticals

Market Cap: US$3.8b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Sarepta Therapeutics

Market Cap: US$2.3b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Abeona Therapeutics

Market Cap: US$246.6m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Biogen

Market Cap: US$22.6b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

ARS Pharmaceuticals

Market Cap: US$885.5m

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

United Therapeutics

Market Cap: US$19.2b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Dynavax Technologies

Market Cap: US$1.2b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

Regeneron Pharmaceuticals

Market Cap: US$66.9b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Exact Sciences

Market Cap: US$12.2b

Provides cancer screening and diagnostic test products in the United States and internationally.

Merck

Market Cap: US$214.8b

Operates as a healthcare company worldwide.

Veru

Market Cap: US$43.2m

A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).

Arcutis Biotherapeutics

Market Cap: US$3.1b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Incyte

Market Cap: US$18.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Bristol-Myers Squibb

Market Cap: US$93.8b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

ANI Pharmaceuticals

Market Cap: US$1.9b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Iovance Biotherapeutics

Market Cap: US$712.9m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Harmony Biosciences Holdings

Market Cap: US$1.6b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Bio-Rad Laboratories

Market Cap: US$8.5b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

CureVac

Market Cap: US$1.2b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Pfizer

Market Cap: US$140.1b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Amicus Therapeutics

Market Cap: US$2.8b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.

Day One Biopharmaceuticals

Market Cap: US$762.1m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.